3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
6
Neoplasm Metastasis
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Multiple Myeloma
2
Lymphoma, Follicular
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Thyroid cancer, follicular
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Spinocerebellar Degenerations
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Renal Insufficiency
1
Recurrence
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Malignant Solid Neoplasm
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Leukemia, Lymphoid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hepatic Insufficiency
1
Gallbladder Neoplasms
1
Digestive System Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Interventions
Temozolomide
47
Bevacizumab
41
Radiotherapy
17
Magnetic Resonance Spectroscopy
14
Irinotecan
11
Nivolumab
8
Everolimus
7
Radiation
6
poly ICLC
5
X-Rays
5
Phantoms, Imaging
5
Carboplatin
5
pembrolizumab
4
fluorodopa F 18
4
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Granulocyte-Macrophage Colony-Stimulating Factor
4
Erlotinib Hydrochloride
4
Carmustine
4
ribociclib
3
palbociclib
3
ivosidenib
3
antineoplaston A10
3
Vorinostat
3
Radiotherapy, Intensity-Modulated
3
Radiosurgery
3
Modafinil
3
Lomustine
3
Biopsy
3
veliparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Glioma
×
copanlisib
×
Clear all
No trials found.